Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTouchstar Plc Regulatory News (TST)

Share Price Information for Touchstar Plc (TST)

Share Price is delayed by 15 minutes
Get Live Data
77.00    2.00 (2.67%)
Bid:
74.00
Ask:
80.00
Spread: 6.00 (8.108%)
Market Cap: £6.10m
TST Live PriceLast checked at - London Stock Exchange

Intraday Touchstar Plc Share Chart

Share Buyback Programme

6 May 2025 09:22

RNS Number : 4840H
Touchstar PLC
06 May 2025
 

 

6 May 2025

 

 

Touchstar plc

(the "Company", "Touchstar" or the "Group")

 

Share Buyback Programme

Touchstar plc (AIM: TST), suppliers of mobile data computing solutions and managed services to a variety of industrial sectors, is pleased to announce the launch of an initial share buyback programme of ordinary shares of 5 pence each ("Ordinary Shares") to repurchase up to £100,000 worth of Ordinary Shares (the "Buyback Programme"), effective from today.

The Board considers the Buyback Programme to be in the best interests of all shareholders, given the cash generative nature of the business and the surplus cash the Company holds. It is also consistent with the Board's desire to increase shareholder value/ returns.

The Company has appointed its broker, Zeus Capital Limited ("Zeus"), to manage the Buyback Programme to repurchase Ordinary Shares on its behalf and entered into an irrevocable and non-discretionary arrangement on 6 May 2025 with Zeus, to enable Zeus to conduct the Buyback Programme on a broker-managed basis. Zeus will make trading decisions in relation to the Buyback Programme independently of the Company, within certain defined parameters.

The Buyback Programme commences today and will end on the earlier of the date upon which the aggregate consideration paid for Ordinary Shares reaches £100,000 or the date of the Company's next annual general meeting (expected to be in late June 2025) (the "Buyback Period"). During the Buyback Period the Company has no power to invoke any changes to the authority and any purchases will be undertaken by Zeus, acting independently of, and uninfluenced by the Company. It is expected that the Buyback programme will be extended.

 

Ordinary Share repurchases will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volume. The Buyback Programme is in accordance with the Company's general authority to purchase a maximum of 820,007 Ordinary Shares, granted by its shareholders at the Annual General Meeting held on 3 June 2024, including that the maximum price paid per Ordinary Share will be no more than: a) 105 per cent. of the average trading price of the Ordinary Shares as derived from the middle market quotations for an Ordinary Share on the London Stock Exchange Daily Official List for the five trading days immediately preceding the date on which an Ordinary Share is contracted to be purchased; and b) the higher of the price of the last independent trade and the highest current independent purchase bid for Ordinary Shares on the trading venue where the purchase is carried out.

 

Under the Buyback Programme, the repurchased shares will either be cancelled or held in treasury at the Company's discretion for later reissue or cancellation. Shares held in treasury are not entitled to dividends and have no voting rights at the Company's general meetings.

 

The Buyback Programme will be conducted within the parameters of the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation 2016/1052/EU (each as in force in the UK from time to time, including where relevant pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2019.

 

The Company will make further announcements in due course following any share purchases conducted through the Buyback Programme.

 

Following this announcement, the issued share capital of the Company remains unchanged at 8,475,077 and the Company holds 275,000 shares in treasury. The total voting rights in the Company is 8,200,077, which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Team Internet under the FCA's Disclosure Guidance and Transparency Rules.

 

The Company confirms that it currently has no unpublished price sensitive information.

 

 

 

For further information, please contact:

 

Touchstar plc

Ian Martin

Mark Hardy

www.touchstarplc.com

0161 874 5050

0161 874 5050

 

Zeus - Nominated Adviser & Broker

Investment Banking - Mike Coe/Darshan Patel

 

0203 829 5000

Information on Touchstar plc can be seen at: www.touchstarplc.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGIGDUGDGDGUL
Date   Source Headline
9th Oct 20245:11 pmRNSForm 8.3 - Touchstar PLC
9th Oct 20242:14 pmRNSForm 8.3 - Touchstar PLC
9th Oct 20241:09 pmRNSForm 8.3 - Touchstar PLC
8th Oct 20244:16 pmRNSForm 8.3 - Touchstar PLC
8th Oct 20243:28 pmRNSForm 8.3 - Touchstar PLC
7th Oct 202412:02 pmRNSForm 8.3 - Touchstar plc
7th Oct 202410:35 amRNSForm 8.3 - Touchstar PLC
4th Oct 20241:52 pmRNSForm 8.3 - Touchstar plc
4th Oct 202410:23 amRNSForm 8.3 - Touchstar PLC
3rd Oct 20247:00 amRNSForm 8 (OPD) (Touchstar plc)
2nd Oct 202410:11 amRNSRule 2.9 Announcement
26th Sep 20241:44 pmRNSForm 8.3 - Touchstar plc
26th Sep 20247:01 amRNSInterim Results
26th Sep 20247:00 amRNSStrategic Review
3rd Sep 20242:10 pmRNSNotice of Interim Results
15th Jul 20247:00 amRNSChange of Adviser
3rd Jun 20243:36 pmRNSRESULT OF AGM
30th Apr 202412:51 pmRNSAnnual Report & Notice of Annual General Meeting
17th Apr 20247:00 amRNSFinal Results
11th Mar 20247:00 amRNSTrading Update
16th Jan 20249:16 amRNSGrant of options
13th Dec 20237:00 amRNSDirector Appointment
9th Nov 202311:14 amRNSTransaction in Own Shares and Total Voting Rights
12th Sep 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Sep 20231:29 pmRNSInterim Results Correction
7th Sep 20237:00 amRNSInterim results
4th Aug 202311:25 amRNSHolding(s) in Company
4th Aug 20239:53 amRNSHolding(s) in Company
4th Aug 20237:00 amRNSDirector Dealing
3rd Aug 20233:36 pmRNSTransaction in Own Shares & TVR
31st Jul 20239:59 amRNSHolding(s) in Company
31st Jul 20239:55 amRNSHolding(s) in Company
21st Jun 20237:00 amRNSDividend Policy and Share Buy-Backs
22nd May 20232:54 pmRNSResult of AGM
26th Apr 20237:00 amRNSCapital Reduction
18th Apr 20237:00 amRNSFinal Results
23rd Jan 20237:00 amRNSTrading Update
8th Nov 20227:00 amRNSContract Award
3rd Oct 20229:28 amRNSGrant of options
15th Sep 20227:00 amRNSInterim Results
12th Aug 20229:12 amRNSHolding(s) in Company
26th Jul 20228:02 amRNSTrading Update
20th Jun 20223:00 pmRNSResult of AGM
26th Apr 20227:00 amRNSFinal Results
24th Jan 20227:00 amRNSFull Year Trading Update
20th Oct 202112:25 pmRNSHolding(s) in Company
13th Sep 20217:00 amRNSInterim Results
23rd Jun 20211:53 pmRNSResult of AGM
23rd Jun 20217:00 amRNSAGM Statement
18th Jun 20211:00 pmRNSAGM Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.